Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00628147 · ClinicalTrials.gov registry record · Phase 4

Clinical Evaluation of Narrow Band Imaging Colonoscope

A Phase 4 study of Colonic Neoplasms, sponsored by VA Palo Alto Health Care System.

Completed
Registry status
Phase 4
Development phase
284
Enrollment target
1
Study location

NCT00628147: Completed Phase 4 study of Colonic Neoplasms, sponsored by VA Palo Alto Health Care System.

NCT00628147 is a Phase 4 study of Colonic Neoplasms that has completed, run by VA Palo Alto Health Care System. The registered enrollment target is 284 participants, below the 1,503-participant average among 14 other Colonic Neoplasms trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00628147, a Phase 4 study of Colonic Neoplasms, has completed, sponsored by VA Palo Alto Health Care System.

COMPLETED
Registry status
Phase 4
Development phase
284 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to determine if colonoscopic examination using a colonoscope with a narrow band imaging light is more effective at detecting polyps compared to a colonoscope with standard full spectrum white light.

Conditions Studied

Interventions

  • DEVICE Narrow band imaging colonoscope

Study Locations (1)

California

  • VAPaloAltoHCS - Palo Alto

Trial Details

FieldValue
Enrollment Target 284 participants
Start Date 2006-01
Est. Completion 2007-03
Phase Phase 4
VA Palo Alto Health Care System

34 total trials

What the finished NCT00628147 record still lists

NCT00628147 is an interventional study that assigns participants to a tested intervention. The registered 284 participants enrollment target is mid-sized for trials with a published cap, below the 1,503-participant average among 14 other Colonic Neoplasms trials with a reported enrollment target (81% lower).

The record links to 1 condition, with Colonic Neoplasms appearing as the primary indexed condition, and to 1 intervention - of which Narrow band imaging colonoscope is the first listed.

NCT00628147 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT00628147 about?

NCT00628147 is a clinical study titled "Clinical Evaluation of Narrow Band Imaging Colonoscope". The purpose of the study is to determine if colonoscopic examination using a colonoscope with a narrow band imaging light is more effective at detecting polyps compared to a colonoscope with standard full spectrum white light.

What is the current status of trial NCT00628147?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 284 participants. The study started on 2006-01. Estimated completion is 2007-03.

What conditions does trial NCT00628147 study?

This clinical trial studies the following conditions: Colonic Neoplasms.

What interventions are being tested in trial NCT00628147?

The interventions under investigation include: Narrow band imaging colonoscope (DEVICE).

Who is sponsoring clinical trial NCT00628147?

This trial is sponsored by VA Palo Alto Health Care System, which has 34 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00628147 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Colonic Neoplasms

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00628147's enrollment target sits among peer trials

284 8th of 14 higher than 7 of 14 other Colonic Neoplasms trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Colonic Neoplasms trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05263206 · 284 participants · Phase 3

    Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)

  • NCT05769218 · 284 participants · NA

    PrEP and MOUD Rapid Access for Persons Who Inject Drugs: The CHORUS+ Study

  • NCT06856577 · 284 participants · Phase 3

    Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-Related Macular Degeneration

  • NCT06963034 · 284 participants · Phase 3

    NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00628147, the US trial registry maintained by the National Library of Medicine. NCT00628147 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.